New drug combo aims to stop advanced cervical cancer from returning
Disease control
Not yet recruiting
This study tests whether adding two drugs, pembrolizumab and lenvatinib, to standard chemoradiation can keep high-risk cervical cancer from coming back. About 87 adults with advanced cervical cancer will receive the drugs alongside radiation and brachytherapy. The main goal is to…
Phase: PHASE2 • Sponsor: Prof. Dr. Remi A. Nout • Aim: Disease control
Last updated May 17, 2026 13:59 UTC